80 patients were enrolled in our study, including 29 patients with PTCL-NOS, 33 with AITL, 12with ALCL (6 with ALK positive) and 6 with EATL. The gene discussed is ALK; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.